International audienceBackground: The 'obesity paradox' suggests that higher body mass index (BMI) is associated with better survival values in metastatic melanoma patients, especially those receiving targeted and immune checkpoint inhibitor therapy. Higher BMI is also associated with higher incidences of treatment-related adverse events (TRAEs). This study assesses whether BMI is associated with survival outcomes and adverse events in metastatic melanoma patients with systemic therapy.Patients and methods: This multicentric retrospective study, conducted from 1 March 2013 to 29 April 2019, enrolled adults with unresectable stage III or IV melanoma from the French multicentric prospective cohort-MelBase (NCT02828202). Patients with first-li...
A male gender driven obesity paradox (improved survival for overweight/obese patients compared to no...
Excess body weight has been identified as a risk factor for many types of cancers, and for the major...
Item does not contain fulltextPURPOSE: Obesity is associated with an increased risk of development a...
International audienceBackground: The 'obesity paradox' suggests that higher body mass index (BMI) i...
BackgroundObesity has been linked to increased mortality in several cancer types; however, the relat...
Background Obesity is a risk factor for malignancy; however, its prognostic role in patients with me...
INTRODUCTION:Immunotherapy is a well-established treatment option in patients with metastatic melano...
IntroductionImmunotherapy is a well-established treatment option in patients with metastatic melanom...
International audienceBackground: High Body mass index (BMI) is a risk factor for breast cancer amon...
While the FDA approval of targeted and immune therapies in metastatic melanoma (MM) have dramaticall...
Background Immune checkpoint inhibitors (ICIs) have transformed treatment for melanoma, but identify...
A male gender driven obesity paradox (improved survival for overweight/obese patients compared to no...
Excess body weight has been identified as a risk factor for many types of cancers, and for the major...
Item does not contain fulltextPURPOSE: Obesity is associated with an increased risk of development a...
International audienceBackground: The 'obesity paradox' suggests that higher body mass index (BMI) i...
BackgroundObesity has been linked to increased mortality in several cancer types; however, the relat...
Background Obesity is a risk factor for malignancy; however, its prognostic role in patients with me...
INTRODUCTION:Immunotherapy is a well-established treatment option in patients with metastatic melano...
IntroductionImmunotherapy is a well-established treatment option in patients with metastatic melanom...
International audienceBackground: High Body mass index (BMI) is a risk factor for breast cancer amon...
While the FDA approval of targeted and immune therapies in metastatic melanoma (MM) have dramaticall...
Background Immune checkpoint inhibitors (ICIs) have transformed treatment for melanoma, but identify...
A male gender driven obesity paradox (improved survival for overweight/obese patients compared to no...
Excess body weight has been identified as a risk factor for many types of cancers, and for the major...
Item does not contain fulltextPURPOSE: Obesity is associated with an increased risk of development a...